The Next Big Thing ...
Health Care: Drugs
Idera Pharmaceuticals Inc. (IDRA: NASDAQ)
$1.20 0.04 | 3.45%
02/09/12 - 03:59 PM ET
25.69K / 44.80K
Vol / Avg. Vol:1.19 / 1.16
Open / Prev. Close:1.15 - 1.31
Today's Range:0.95 - 3.10
52 Wk Range:14.29%
Performance YTD:TheStreet Rating:
Portfolios with IDRA
- Portfolio NameUser Type
- ContributorSmall-Cap Short Squeezes
- UserWill's Watchlist
Latest IDRA Headlines from TheStreet
- Earnings Roundup: National Semiconductor, Buckle 03.11.09 | 10:03 am
- Idera Pharmaceuticals Reports 4Q Profit 03.11.09 | 08:03 am
- Four Biotechs on the Speculative Side 07.15.08 | 12:07 pm
- Wednesday's Health Winners & Losers 12.26.07 | 03:12 pm
- Idera, Merck KGaA Ink R&D Deal 12.19.07 | 11:12 am
Press Releases for IDRA
- Idera Pharmaceuticals To Present At BIO CEO Conference February 14th, 2012 - Business Wire 02.06.12 | 09:02 am
- Idera Pharmaceuticals Announces Favorable Data From Phase 1b Study Of IMO-2055 In Combination With Tarceva® And Avastin® In Patients With Advanced Non-Small Cell Lung Cancer - Business Wire 01.20.12 | 08:01 am
- Idera Pharmaceuticals Announces Selection Of Toll-like Receptor Agonist Candidates For Evaluation As Vaccine Adjuvants By Merck - Business Wire 01.09.12 | 07:01 am
- Idera Pharmaceuticals Presents Data In Preclinical Models Of Lymphoma On IMO-4200, A Dual Agonist Of TLRs 7 And 8, At The American Society For Hematology Meeting - Business Wire 12.13.11 | 04:12 pm
- Idera Pharmaceuticals Announces FDA Authorization To Proceed With A Phase 2 Clinical Trial Of IMO-3100 In Patients With Psoriasis - Business Wire 12.01.11 | 08:12 am
- Idera Pharmaceuticals Regains Global Rights To IMO-2055 In Oncology From Merck KGaA - Business Wire 11.30.11 | 08:11 am
- Idera Announces Presentation On Preclinical Studies Of TLR Antagonist Candidate In Models Of Atherosclerosis At American Heart Association Scientific Sessions 2011 - Business Wire 11.16.11 | 02:11 pm
- Idera Pharmaceuticals Presents Preclinical Data On Its Gene-silencing Oligonucleotides (GSOs) At EuroTIDES 2011 Conference - Business Wire 11.15.11 | 08:11 am
- Idera Pharmaceuticals Reports Third Quarter 2011 Financial Results - Business Wire 11.09.11 | 07:11 am
- Idera Pharmaceuticals Completes $9.5 Million Financing - Business Wire 11.04.11 | 04:11 pm
Partner Headlines for IDRA
- Rodman & Renshaw Reiterates Idera Pharmaceuticals Market Outperform, Lowers PT - Benzinga 07.14.11 | 04:07 pm
- 5 Companies Providing Clinical Trial Updates This Week - Seeking Alpha 07.08.11 | 03:07 pm
- Two IPOs Brave the Markets, Two Enter the Queue: Biotech's Latest Deals - Seeking Alpha 08.08.10 | 08:08 am
- Volume Talks Wednesday: A Bullish Biotech Breakout Option Play - SeekingAlpha.com 03.25.10 | 12:03 am
